IBDEI1EX ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22598,1,4,0)
 ;;=4^D70.3
 ;;^UTILITY(U,$J,358.3,22598,2)
 ;;=^334041
 ;;^UTILITY(U,$J,358.3,22599,0)
 ;;=D70.9^^102^1142^74
 ;;^UTILITY(U,$J,358.3,22599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22599,1,3,0)
 ;;=3^Neutropenia NOS
 ;;^UTILITY(U,$J,358.3,22599,1,4,0)
 ;;=4^D70.9
 ;;^UTILITY(U,$J,358.3,22599,2)
 ;;=^334186
 ;;^UTILITY(U,$J,358.3,22600,0)
 ;;=M85.80^^102^1142^76
 ;;^UTILITY(U,$J,358.3,22600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22600,1,3,0)
 ;;=3^Osteopenia
 ;;^UTILITY(U,$J,358.3,22600,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,22600,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,22601,0)
 ;;=M81.0^^102^1142^77
 ;;^UTILITY(U,$J,358.3,22601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22601,1,3,0)
 ;;=3^Osteoporosis,Age-Related w/o Fx
 ;;^UTILITY(U,$J,358.3,22601,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,22601,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,22602,0)
 ;;=G62.9^^102^1142^78
 ;;^UTILITY(U,$J,358.3,22602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22602,1,3,0)
 ;;=3^Peripheral Neuropathy
 ;;^UTILITY(U,$J,358.3,22602,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,22602,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,22603,0)
 ;;=B59.^^102^1142^79
 ;;^UTILITY(U,$J,358.3,22603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22603,1,3,0)
 ;;=3^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,22603,1,4,0)
 ;;=4^B59.
 ;;^UTILITY(U,$J,358.3,22603,2)
 ;;=^5000734
 ;;^UTILITY(U,$J,358.3,22604,0)
 ;;=J15.8^^102^1142^80
 ;;^UTILITY(U,$J,358.3,22604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22604,1,3,0)
 ;;=3^Pneumonia,Oth Spec Bacteria
 ;;^UTILITY(U,$J,358.3,22604,1,4,0)
 ;;=4^J15.8
 ;;^UTILITY(U,$J,358.3,22604,2)
 ;;=^95571
 ;;^UTILITY(U,$J,358.3,22605,0)
 ;;=J13.^^102^1142^81
 ;;^UTILITY(U,$J,358.3,22605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22605,1,3,0)
 ;;=3^Pneumonia,Pneumococcal
 ;;^UTILITY(U,$J,358.3,22605,1,4,0)
 ;;=4^J13.
 ;;^UTILITY(U,$J,358.3,22605,2)
 ;;=^5008170
 ;;^UTILITY(U,$J,358.3,22606,0)
 ;;=J18.9^^102^1142^82
 ;;^UTILITY(U,$J,358.3,22606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22606,1,3,0)
 ;;=3^Pneumonia,Unspec
 ;;^UTILITY(U,$J,358.3,22606,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,22606,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,22607,0)
 ;;=A81.2^^102^1142^83
 ;;^UTILITY(U,$J,358.3,22607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22607,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,22607,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,22607,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,22608,0)
 ;;=B86.^^102^1142^84
 ;;^UTILITY(U,$J,358.3,22608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22608,1,3,0)
 ;;=3^Scabies
 ;;^UTILITY(U,$J,358.3,22608,1,4,0)
 ;;=4^B86.
 ;;^UTILITY(U,$J,358.3,22608,2)
 ;;=^108096
 ;;^UTILITY(U,$J,358.3,22609,0)
 ;;=T50.905A^^102^1142^85
 ;;^UTILITY(U,$J,358.3,22609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22609,1,3,0)
 ;;=3^Side Effect of Medication,Init Encntr
 ;;^UTILITY(U,$J,358.3,22609,1,4,0)
 ;;=4^T50.905A
 ;;^UTILITY(U,$J,358.3,22609,2)
 ;;=^5052160
 ;;^UTILITY(U,$J,358.3,22610,0)
 ;;=J01.90^^102^1142^86
 ;;^UTILITY(U,$J,358.3,22610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22610,1,3,0)
 ;;=3^Sinusitis,Acute
 ;;^UTILITY(U,$J,358.3,22610,1,4,0)
 ;;=4^J01.90
 ;;^UTILITY(U,$J,358.3,22610,2)
 ;;=^5008127
 ;;^UTILITY(U,$J,358.3,22611,0)
 ;;=J32.9^^102^1142^87
 ;;^UTILITY(U,$J,358.3,22611,1,0)
 ;;=^358.31IA^4^2
